PYC Therapeutics Limited (AU:PYC) has released an update.
PYC Therapeutics Limited has announced the issue of 2 million unlisted options, expiring on July 1, 2028, with an exercise price of $0.17 each. The securities, part of an employee incentive scheme, are set to be issued on July 1, 2024, and will not be quoted on the ASX. This move indicates PYC Therapeutics’ efforts to incentivize their employees through stock options, potentially signaling confidence in the company’s future.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.
